Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 94 of 95, showing 5 Applications out of 471 total, starting on record 466, ending on 470

# Protocol No Study Title Investigator(s) & Site(s)

466.

ECCT/14/12/01   Rivaroxaban for Long-term and Initial Anticoagulation in Venous Thromboembolism (VTE)
    XALIA LEA- Xarelto® for Long-term and  Initial Anticoagulation in Venous  Thromboembolism (VTE) in Latin America,  EMEA and Asia   
Principal Investigator(s)
1. Anne Njeri Mugera Njambi Mugera
2. Dr. Martin N Wanyoike Njoroge Wanyoike
3. Charles Muthui Kariuki Muthui Kariuki
4. FEROZ ALI Allibhoy
Site(s) in Kenya
1. Primecare Heart Clinic (Nairobi City county)
2. Dr. Silversteins Clinic (Nairobi City county)
3. Nairobi Cardiovascular Clinic (Nairobi City county)
4. Agah Khan Kisumu (Kisumu county)
 
View

467.

ECCT/13/04/02  
    XANTUS EMEA-LA. Xarelto® on prevention of stroke and non-central nervous system systemic embolism in patients with non-valvular atrial fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A non-interventional study   
Principal Investigator(s)
1. Dr Charles Muthui Kariuki
Site(s) in Kenya
Nairobi Cardiovascular Clinic
 
View

468.

ECCT/14/03/02   Rivaroxaban on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation
    XANTUS-EL, Xarelto on prevention of stroke and non-central nervous system systemic embolism in patients with non valvular atrial fibrillation - a non interventional study, XA 1206 (IMPACT No. 16691)       
Principal Investigator(s)
1. Warshow Majid Mbarak
Site(s) in Kenya
1. MP Shah Hospital (Nairobi City county)
 
View

469.

ECCT/22/11/04   YWF:03
    YWF:03: A PHASE III, MULTICENTER, DOUBLE BLIND, RANDOMIZED STUDY OF SII YELLOW FEVER VACCINE TO COMPARE SAFETY AND IMMUNOGENICITY WITH STAMARIL®       
Principal Investigator(s)
1. Videlis Nduba
2. Otieno Walter
Site(s) in Kenya
1. KEMRI-CRDR (Nairobi City county)
2. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
 
View

470.

ECCT/16/08/02   Zeenk study
    Zeenk Acceptability Study   
Principal Investigator(s)
1. Margaret Oluka
2. David Kimutai
3. Caren Emadu
Site(s) in Kenya
1. Mbagathi District Hospital (Nairobi City county)
2. Mama Lucy Kibaki Hospital (Nairobi City county)
 
View